Scarica l'app Stockscreener
6.50
0.15%
-0.010
Dopo l'orario di chiusura:
6.50
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$6.51
Aprire:
$6.39
Volume 24 ore:
963.29K
Relative Volume:
0.65
Capitalizzazione di mercato:
$670.17M
Reddito:
$17.82M
Utile/perdita netta:
$-51.99M
Rapporto P/E:
-5.827
EPS:
-1.1155
Flusso di cassa netto:
$-45.31M
1 W Prestazione:
-6.74%
1M Prestazione:
-19.95%
6M Prestazione:
+53.66%
1 anno Prestazione:
+27.20%
Intervallo 1D:
$6.33
$6.64
Intervallo di 1 settimana:
$6.33
$6.935
Portata 52W:
$2.62
$8.64
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Nome
Achieve Life Sciences Inc
Settore
Industria
Telefono
425-686-1500
Indirizzo
22722 29TH DR. SE, SEATTLE, BC
Compare ACHV vs VRTX, REGN, MRNA, ARGX, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
6.50 | 670.17M | 17.82M | -51.99M | -45.31M | -1.1155 |
VRTX
Vertex Pharmaceuticals Inc
|
535.17 | 135.64B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
819.09 | 84.33B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
202.63 | 80.90B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
875.76 | 55.07B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
382.27 | 43.24B | 5.76B | 514.49M | 1.10B | 4.4813 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-09-30 | Iniziato | Stifel | Buy |
| 2026-08-13 | Iniziato | Morgan Stanley | Overweight |
| 2026-06-26 | Ripresa | Raymond James | Strong Buy |
| 2026-04-21 | Iniziato | Canaccord Genuity | Buy |
| 2025-11-25 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-08-21 | Iniziato | H.C. Wainwright | Buy |
| 2024-11-14 | Iniziato | Rodman & Renshaw | Buy |
| 2024-09-27 | Iniziato | Raymond James | Strong Buy |
| 2023-05-10 | Reiterato | Maxim Group | Buy |
| 2021-06-23 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Achieve Life Sciences Inc Borsa (ACHV) Ultime notizie
Achieve Life Sciences (NASDAQ:ACHV) Stock Falls 6%Should You Sell? - MarketBeat
Achieve Life Sciences, Inc. (ACHV)What Are Investment Firms Saying About This Stock? - MarketBeat
Non-controlling/minority interest of Achieve Life Sciences, Inc. – HAN:SP4P - TradingView
Achieve Life Sciences (NASDAQ:ACHV) Share Price Breaks Above 200-Day Moving AverageTime to Sell? - MarketBeat
Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications - GlobeNewswire
Achieve Life Sciences CFO Benjamin Halladay Files Initial SEC Ownership Disclosure - Kalkine Media
CFO receives a 200,000-share stock grant plus options at Achieve Life Sciences (ACHV). - Stock Titan
[Form 3] ACHIEVE LIFE SCIENCES, INC. Initial Statement of Beneficial Ownership - Stock Titan
Achieve Life Sciences Announces Granting of New Hire Inducement Awards - Yahoo Finance
Achieve Life Sciences Announces Granting of New Hire Inducement Awards - GlobeNewswire
A new finance chief received stock awards with different vesting schedules over four years. - Stock Titan
Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates - Lelezard
Achieve Life Sciences, Inc. $ACHV Shares Newly Bought by Bank of America Corp DE - MarketBeat
Achieve Life Sciences appoints Benjamin Halladay as chief financial officer - Investing.com
Achieve Life Sciences (ACHV) Names Benjamin Halladay as CFO Amid Strategic Transition - GuruFocus
Achieve Life Sciences (NASDAQ:ACHV) Shares Down 6.5%Here's What Happened - MarketBeat
Achieve Life Sciences Appoints Benjamin Halladay As CFO - Pulse 2.0
Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer - Yahoo Finance
A CFO who led finance work on a drug company sale of up to $1.1 billion will join Achieve as CFO. - Stock Titan
Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer - GlobeNewswire
Achieve Life Sciences Names Benjamin Halladay CFO - Yahoo Finance
Stifel Initiates Achieve Life Sciences (ACHV) with Buy Rating on Cytisinicline Potential - GuruFocus
Achieve a new Buy at Stifel on potential of smoking cessation drug cytisinicline - Seeking Alpha
Achieve Life Sciences (NASDAQ:ACHV) Shares Gap UpStill a Buy? - MarketBeat
Stifel Initiates Achieve Life Sciences at Buy With $18 Price Target - www.marketscreener.com
Stifel Initiates Achieve Life Sciences at Buy With $18 Price Target - Yahoo Finance
Achieve Life Sciences (NasdaqCM:ACHV) Stock Forecast & Analyst Predictions - Simply Wall Street
Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat
Achieve Life Sciences to Present 52-Week Cytisinicline - GlobeNewswire
A yearlong quit-smoking and vaping study involved 475 adults. Results will be presented Oct. 20. - Stock Titan
Achieve Life Sciences (ACHV) Short Interest & Short Float | Updated Sep 2026 - MarketBeat
Achieve Life Sciences: Thesis Intact, Setup Remains Constructive (Rating Downgrade) (ACHV) - Seeking Alpha
Achieve Life Sciences: A Funded Manufacturing Reset, Not A Broken Clinical Thesis - Seeking Alpha
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Achieve Life Sciences (NASDAQ:ACHV) Stock Crosses Above 200-Day Moving AverageTime to Sell? - MarketBeat
Bank of New York Mellon Corp Buys Shares of 218,126 Achieve Life Sciences, Inc. $ACHV - MarketBeat
Wellington Management Group LLP Buys New Stake in Achieve Life Sciences, Inc. $ACHV - MarketBeat
Frazier Life Sciences Management L.P. Buys New Stake in Achieve Life Sciences, Inc. $ACHV - MarketBeat
Achieve Life Sciences Stock Price Forecast. Should You Buy ACHV? - StockInvest.us
Achieve Life Sciences Grants Equity Awards to 7 New Employees Under 2024 Inducement Plan - quiverquant.com
Seven new employees receive stock awards from Achieve Life Sciences - Stock Titan
Achieve Life Sciences (NASDAQ:ACHV) Sets New 1-Year HighHere's What Happened - MarketBeat
Achieve Life Sciences Announced Granting of New Hire Inducement Awards - Yahoo Finance
Achieve Life Sciences Announced Granting of New Hire Inducement Awards - GlobeNewswire
BlackRock Inc. Invests $34.43 Million in Achieve Life Sciences, Inc. $ACHV - MarketBeat
Achieve Life Sciences (NASDAQ:ACHV) Stock Price Up 5.2%Time to Buy? - MarketBeat
Alyeska Investment Group L.P. Acquires Shares of 1,925,722 Achieve Life Sciences, Inc. $ACHV - MarketBeat
Jupiter Topco LLC Acquires Shares of 2,751,032 Achieve Life Sciences, Inc. $ACHV - MarketBeat
Achieve Life Sciences Inc. (ACHV) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Spruce Street Capital LP Purchases Shares of 736,637 Achieve Life Sciences, Inc. $ACHV - MarketBeat
Achieve Life Sciences Inc Azioni (ACHV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Achieve Life Sciences Inc Azioni (ACHV) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Stewart Richard Alistair | Director |
Aug 19 '26 |
Proposed Sale |
7.52 |
20,626 |
155,108 |
0 |
2.10%
2.26%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):